InSphero

A long-lived, organotypic 3D human liver model for more predictive in vitro toxicity...

A rapid, robust imager for monitoring spheroid growth and morphology. The Dainip...

The industry-leading solution for reliable, scaffold-free 3D cell-based assays. ...

A luminescent ATP assay for monitoring cell viability in 3D microtissues. The 3D ...

Long-lived, standardized pancreatic islet microtissues for diabetes & metabolic res...

Company Profile

InSphero is a leading supplier of organotypic, biological microtissues for biomimetic drug testing. The company, headquartered in Zurich, Switzerland, currently collaborates with more than ten global pharmaceutical and cosmetics companies to implement the company’s patent-pending microtissue technology in the customer’s development work-flow. InSphero is a spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich and was founded in 2009 by Dr. Jan Lichtenberg, Dr. Jens Kelm, Dr. Wolfgang Moritz and Prof. Dr. Dr. Simon P. Hoerstrup. InSphero has its production, laboratory and office space at the Technopark in Zurich, Switzerland. InSphero was recognized for its scientific and commercial achievements with a number of awards, including the VentureKick award, Heuberger Entrepreneurial Award and CTIstartup certification.

InSphero’s founders combine more than 15 years of experience in microtissue engineering and over 10 years in microfluidics and laboratory automation with the goal to deliver highly functional, reliable and easy-to-use microtissues.



Contact InSphero

InSphero AG
Wagistrasse 27
8952 Schlieren
Switzerland
+41-44-515049-0
Company Website

Request Info

Advertisement

Advertisement